COMMUNIQUÉS West-GlobeNewswire
-
La FDA accorde un examen prioritaire au Dupixent® (dupilumab) dans le traitement potentiel de la dermatite atopique modéré à sévère non contrôlée de l'adolescent
06/11/2018 - 07:01 -
Corvus Pharmaceuticals to Webcast Investor & Analyst Event on November 10, 2018
06/11/2018 - 00:31 -
OpGen Announces Date of Third Quarter 2018 Financial Results Conference Call
05/11/2018 - 23:23 -
Kane Biotech Appoints Dr. Gordon Guay as Chief Scientific Officer
05/11/2018 - 22:30 -
Syneos Health to Present at the Jefferies 2018 London Healthcare Conference
05/11/2018 - 22:30 -
The Ensign Group to Present at the 2018 Stephens Fall Investment Conference on Tuesday, November 6, 2018
05/11/2018 - 22:30 -
ReWalk Robotics to Report Third Quarter 2018 Financial Results on November 8, 2018
05/11/2018 - 22:30 -
Clearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018 – Conference Call to Follow
05/11/2018 - 22:30 -
INSYS Therapeutics Reports Third Quarter 2018 Results
05/11/2018 - 22:16 -
Strongbridge Biopharma plc to Present at the Stifel 2018 Healthcare Conference
05/11/2018 - 22:15 -
INSYS Therapeutics to Assess Strategic Alternatives for Opioid-Related Assets
05/11/2018 - 22:15 -
Otonomy Reports Third Quarter 2018 Financial Results and Provides Corporate Update
05/11/2018 - 22:12 -
EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize Durasert™ Three-Year Treatment for Posterior Segment Uveitis in the Greater China Region
05/11/2018 - 22:11 -
Alder BioPharmaceuticals® Reports Third Quarter 2018 Financial and Operating Results
05/11/2018 - 22:08 -
Iterum Therapeutics plc to Participate in Investor Conferences in November and December
05/11/2018 - 22:05 -
Kura Oncology Reports Third Quarter 2018 Financial Results and Provides Corporate Update
05/11/2018 - 22:05 -
Rubius Therapeutics to Announce Third Quarter 2018 Financial Results
05/11/2018 - 22:05 -
Akcea Reports Financial Results and Highlights for Third Quarter 2018
05/11/2018 - 22:05 -
Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update
05/11/2018 - 22:05
Pages